Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel alphaVbeta3 antagonists show promise for osteoporosis

Dec. 14, 2017

European Commission grants orphan drug designation to KL-1333 for MELAS

Dec. 13, 2017

Alnylam Pharmaceuticals completes rolling NDA submission for patisiran

Dec. 13, 2017

NeuroVive reports interim results from phase I study of KL-1333

Dec. 12, 2017

FDA approves Sanofi's follow-on insulin product

Dec. 12, 2017

University of California identifies new growth factors for bone regeneration

Dec. 12, 2017

FDA expands orphan drug designation for patisiran

Dec. 12, 2017

Merck & Co. divulges new FFA4 receptor agonists

Dec. 11, 2017

Xoma licenses XOMA-358 to Rezolute

Dec. 11, 2017

FDA approves Novo Nordisk's Ozempic for type 2 diabetes

Dec. 7, 2017

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...